(19)
(11) EP 1 301 200 A2

(12)

(88) Date of publication A3:
18.07.2002

(43) Date of publication:
16.04.2003 Bulletin 2003/16

(21) Application number: 01941488.7

(22) Date of filing: 17.05.2001
(51) International Patent Classification (IPC)7A61K 38/25, A61K 38/26, A61K 38/29, A61K 47/12, A61K 47/26
(86) International application number:
PCT/US0115/872
(87) International publication number:
WO 0108/7322 (22.11.2001 Gazette 2001/47)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 19.05.2000 US 205262 P

(71) Applicant: BIONEBRASKA, INC.
Lincoln, NE 68524 (US)

(72) Inventors:
  • HOLMQUIST, Barton
    Lincoln, NE 68528 (US)
  • DORMADY, Daniel, C.
    Omaha, NE 68164 (US)

(74) Representative: Pohlman, Sandra M. et al
Dörries Frank-Molnia & Pohlman,Triftstrasse 13
80538 München
80538 München (DE)

   


(54) PEPTIDE PHARMACEUTICAL FORMULATIONS